Overview
Location
Italy
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2026 | Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets | Alfasigma S.p.A (“Alfasigma” or the “Company”), a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered, today announced its financial results for the fiscal year 2025. Its results reflect a year of str... |
| Sep 9, 2025 | Why Most Global Expansions Fail and What Successful Brands Do to Avoid It | Balancing local relevance with global ambition — a strategic dilemma every brand must face when expanding abroad. Adelaide Raia, General Manager of Alfasigma’s Consumer Health Business Unit and co-author of the new article on global brand e... |
| Sep 9, 2025 | Barcelona-based Remuner raises €5.5 million to turn sales incentives into a growth lever | Remuner, a Spanish AI-powered platform for modern sales compensation, has closed a €5.5 million Seed round to expand internationally, invest further in product development – especially in AI-powered capabilities – and strengthen its positio... |
| Sep 9, 2025 | Remuner raises $6.5M to transform sales incentives with AI-driven automation | Barcelona-based Remuner, the AI-powered platform for modern sales compensation, has closed a $6.5 million seed round. Remuner is a sales compensation platform that helps companies align goals and incentives across teams by fully automating ... |
| Nov 20, 2024 | Forging New Paths: Alfasigma Group and Fangzhou Inc. Chart a Course for Internet Healthcare | SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- On November 13th, a high-level delegation from the Alfasigma Group, led by Mr. Andriy Samoylovych, Chief Commercial Officer of Global Growth Markets, and Ms. Zhou Qin, General Manager of Alfasigma Chi... |
| Oct 20, 2022 | ALFASIGMA ACQUIRES SOFAR'S ENTIRE SHARE CAPITAL, AN ITALIAN PHARMACEUTICAL COMPANY | POMEZIA, Italy, Oct. 20, 2022 /PRNewswire/ -- Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was sc... |
| Jun 22, 2021 | Alfasigma acquires the European license for bentracimab from PhaseBio | BOLOGNA, Italy, 22 giugno 2021 /PRNewswire/ -- Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), for the commercialization of bentracimab in 49 countries across Europe and other ... |
| Apr 1, 2021 | Alfasigma: It's Vein Week from 5th to 11th of April USA - English España - español | |
| Apr 1, 2021 | Alfasigma: It's Vein Week from 5th to 11th of April | BOLOGNA, Italy, April 1, 2021 /PRNewswire/ -- Venous-lymphatic World International Network foundation (v-WIN), a no profit global organization dedicated to research and education in the venous & lymphatic field has developed a public an... |
Show more